Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Icatibant Outcome Survey (IOS) Registry

NCT01034969 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT01034969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01034969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Icatibant Outcome Survey (IOS) Registry
Lead sponsor
Shire
Phase
Observational
Overall status
Completed
Start date
July 10, 2009
Completion date
May 31, 2024
Enrollment
1,761 (actual)
Sites
74

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary angioedema (hae)